NEW YORK -- General Motors (GM) is expected by analysts Thursday to post second-quarter earnings of 78 cents a share on revenue of $38.28 billion.
The automaker said Wednesday that U.S. sales in July declined 6% as fleet sales fell 15% and retail sales fell 3%. Fleet sales account for about a quarter of GM's business.
Sony's (SNE) quarterly losses widened from a year earlier and the Japanese electronics giant reduced its earnings outlook for the fiscal year. Sony posted a loss in the April-June quarter of 24.6 billion yen ($316 million) compared with a year-earlier loss of 15.5 billion, hurt by a strong yen and lower sales of LCD TVs. Sales rose 1.4% to 1.52 trillion yen. Sony lowered its outlook for the fiscal year through March 2013 to a profit of 20 billion yen; it projected 30 billion yen back in May.
Bristol-Myers Squibb (BMY) suspended a mid-stage study of its experimental hepatitis C drug BMS-094 due to a serious safety issue. The safety issue that forced the company to suspend the phase II study of BMS-094 is believed to be heart failure, according to ISI Group analyst Mark Schoenebaum BMS-094 was the sole reason behind Bristol-Myers' $2.5 billion acquisition of Inhibitex last January. Bristol's Hep C Drug Blow Up May Benefit Gilead, Idenix, Vertex Pharma
Yelp (AAPL) posted Wednesday stronger-than-expected second-quarter revenue. Yelp, which lets users find and review restaurants and other places of interest, reported a loss of 3 cents a share on $32.7 million in revenue, up 67% from last year. . Analysts were expecting a loss of 6 cents a share on sales of $30.5. Yelp noted average monthly unique visitors rose 52% from a year earlier to more than 78 million and active local business accounts jumped 113%. Yelp Screams Higher on Strong Revenue
Earnings are expected Thursday from Kraft Foods (KFT), Kellogg (K), Beam (BEAM), Cardinal Health (CAH), Activision Blizzard (ATVI) and DirecTV (DTV).
-- Written by Joseph Woelfel
>To contact the writer of this article, click here: Joseph Woelfel
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV